A nanodiamond is forever. They are brightly fluorescent, infinitely stable, non-toxic, functionalizable and can be used for background-free optical imaging. Early results have improved the signal by as much as 100-fold over conventional fluorescence imaging techniques. Bikanta’s vision is to redefine the boundaries of medical diagnostics by delivering cutting-edge imaging probes and background-free optical imaging.
Overview
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 23, 2015 | A Nano Step For Man, A Giant Leap For Mankind | Ambika Bumb Contributor Ambika Bumb, a Marshall Scholarship graduate of Oxford University, is the co-founder and chief executive of the cancer detection and treatment technology developer, Bikanta. Last month I was invited to join a couple ... |
| Feb 8, 2015 | Female Founder Stories: Ambika Bumb, Founder of Bikanta (YC S14) | Bikanta has developed revolutionary nanodiamond-based technologies that push the boundaries of what can be done with medical imaging for applications like the early detection of cancer. Q: What was your background prior to starting Bikanta... |
| Sep 12, 2014 | Y Combinator Wants You (To Solve Big Problems) | In its last Demo Day, Y Combinator showcased startups that are seeking to solve some of the world’s biggest problems. As in, nuclear energy, health, and quantum computing–all things that are (arguably) more important than how to get food de... |
| Aug 19, 2014 | YC Demo Day Session 1: Gingko Bioworks, Bikanta, Checkr, WalkSource, ClearTax, And More | We’re at the the Computer History Museum in Mountain View, Calif., to see the startups in the Y Combinator Summer 2014 class pitch their wares to investors and the press. There will be four sessions in total today, and we’ll be writing up a... |
| Aug 7, 2014 | Bikanta’s Tiny Diamonds Find Cancer Before It Spreads | Y Combinator-backed biotech company Bikanta wants to find and stop cancer at its source by inserting tiny, fluorescent diamonds inside your body. The brainchild of Dr. Ambika Bumb, who holds a PhD in biomedical engineering from Oxford, thes... |
| YC and Hard Tech Startups | Some people think YC only funds straightforward software startups. That’s definitely not the case — YC’s largest exit to date is a self-driving car company, Cruise Automation, and we’ve funded many other hard technology companies like Gingk... | |
| Founder Stories: Ambika Bumb, Founder of Bikanta (YC S14) | Bikanta has developed revolutionary nanodiamond-based technologies that push the boundaries of what can be done with medical imaging for applications like the early detection of cancer. Q: What was your background prior to starting Bikanta... |
Reviews 0
FAQ about Bikanta
When was Bikanta founded?
Bikanta was founded in 2013.
How much funding has Bikanta raised?
Bikanta has raised $1.7M in total across 1 funding round.
What has the press written about Bikanta?
Parsers VC has collected 8 articles mentioning Bikanta, among them “A Nano Step For Man, A Giant Leap For Mankind” (Dec 23, 2015) and “Female Founder Stories: Ambika Bumb, Founder of Bikanta (YC S14)” (Feb 8, 2015).
Is Bikanta still active?
Yes, Bikanta is active; its latest activity on Parsers VC dates from Jul 21, 2020.